CeMM, biomedical research institute of the Austrian Academy of Sciences and founding member of EU-LIFE is inviting applications for Postdoctoral Fellows in Inflammation Biology.
About the positions:
- The positions are available in the Bergthaler laboratory to investigate fundamental molecular questions in the areas of infection, inflammation and pathology.
- Hypothesis- and data-driven approaches are combined to address pertinent pathophysiological questions on the organ and organism level.
- The host laboratory is interested in local vs. systemic inflammation, immunoregulation, organismal immunometabolism, inter-organ communication and tissue pathology. We employ cutting-edge technologies (e.g. mouse genetics, virus reverse genetics, single cell sequencing, metabolomics, metabolite tracing, CRISPR screens, computational biology) in order to unravel the molecular underpinnings of inflammation.
- Several projects are available which will benefit from established in vivo disease models, preliminary data, strong bioinformatics support, access to world class core facilities (e.g. sequencing, metabolomics, proteomics, drug screens) and an international and highly collaborative environment.
- Applicant must hold PhD in a relevant field viz., Immunology, Virology, Molecular Biology, Genomics, Epigenetics, Tissue Biology, Computational Biology, Technology Development or MD/DVM degree.
- Successful publication track record with at least one first-author paper in a peer-reviewed journal.
- Critical, creative, interdisciplinary and proactive mindset.
- Team player with strong communication skills.
- Apply online and include the following:
- A cover letter
- Academic transcripts
- Contact details of three referees
- Applications will be reviewed on a rolling basis.
- Starting dates are flexible.
|Organization||CeMM Research Center for Molecular Medicine (Austrian Academy of Sciences)|
Immunology, Virology, Molecular Biology, Genomics, Epigenetics, Tissue Biology, Computational Biology, Technology Development
|Eligibility||Open to all nationalities|
|Deadline||31 January 2019|